CVR number 41040203
Industry 32.5000 Manufacture of medical and dental instruments and supplies

Nord-Smil.dk Dentalvarer ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  0.0% 12.1% 28.0% 4.5% 12.4%  
Credit score (0-100)  0 19 1 46 18  
Credit rating  N/A BB B BBB BB  
Credit limit (kDKK)  0.0 -0.0 -0.0 0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 -127 386 2,583 1,938  
EBITDA  0.0 -127 -839 1,219 -4.3  
EBIT  0.0 -127 -1,012 1,027 -196  
Pre-tax profit (PTP)  0.0 -132.6 -1,039.0 978.3 -224.9  
Net earnings  0.0 -103.4 -1,068.2 1,020.2 -224.9  
Pre-tax profit without non-rec. items  0.0 -133 -1,039 978 -225  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 787 595 403  
Shareholders equity total  0.0 -63.7 -1,132 -112 -337  
Interest-bearing liabilities  0.0 0.7 55.5 62.7 257  
Balance sheet total (assets)  0.0 222 1,249 1,847 812  
Net Debt  0.0 0.7 -101 -339 257  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -127 386 2,583 1,938  
Gross profit growth  0.0% 0.0% 0.0% 568.6% -24.9%  
Employees  0 0 3 3 4  
Employee growth %  0.0% 0.0% 0.0% 0.0% 33.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 222 1,249 1,847 812  
Balance sheet change%  0.0% 0.0% 463.4% 47.9% -56.0%  
Added value  0.0 -126.6 -839.2 1,200.2 -4.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 614 -384 -384  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 1.0 -1.0  

Profitability 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% -262.0% 39.8% -10.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -44.4% -75.9% 47.4% -12.6%  
ROI %  0.0% -17,756.8% -3,600.2% 1,738.7% -122.9%  
ROE %  0.0% -46.7% -145.3% 65.9% -16.9%  

Solidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% -22.3% -47.5% -5.7% -29.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -0.6% 12.0% -27.8% -5,947.5%  
Gearing %  0.0% -1.1% -4.9% -56.1% -76.2%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 1,681.3% 96.5% 83.3% 18.0%  

Liquidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.8 0.2 0.6 0.3  
Current Ratio  0.0 0.8 0.2 0.6 0.3  
Cash and cash equivalent  0.0 0.0 156.3 401.4 0.0  

Capital use efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -63.7 -1,994.8 -706.4 -781.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -280 400 -1  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -280 406 -1  
EBIT / employee  0 0 -337 342 -49  
Net earnings / employee  0 0 -356 340 -56